1. Home
  2. ZEO vs FGEN Comparison

ZEO vs FGEN Comparison

Compare ZEO & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZEO
  • FGEN
  • Stock Information
  • Founded
  • ZEO 2005
  • FGEN 1993
  • Country
  • ZEO United States
  • FGEN United States
  • Employees
  • ZEO N/A
  • FGEN N/A
  • Industry
  • ZEO
  • FGEN Biotechnology: Pharmaceutical Preparations
  • Sector
  • ZEO
  • FGEN Health Care
  • Exchange
  • ZEO NYSE
  • FGEN Nasdaq
  • Market Cap
  • ZEO 31.6M
  • FGEN 34.5M
  • IPO Year
  • ZEO N/A
  • FGEN 2014
  • Fundamental
  • Price
  • ZEO $2.16
  • FGEN $0.55
  • Analyst Decision
  • ZEO
  • FGEN
  • Analyst Count
  • ZEO 0
  • FGEN 0
  • Target Price
  • ZEO N/A
  • FGEN N/A
  • AVG Volume (30 Days)
  • ZEO 1.8M
  • FGEN 705.5K
  • Earning Date
  • ZEO 03-18-2025
  • FGEN 02-24-2025
  • Dividend Yield
  • ZEO N/A
  • FGEN N/A
  • EPS Growth
  • ZEO N/A
  • FGEN N/A
  • EPS
  • ZEO N/A
  • FGEN N/A
  • Revenue
  • ZEO $77,582,314.00
  • FGEN $180,015,000.00
  • Revenue This Year
  • ZEO N/A
  • FGEN $21.91
  • Revenue Next Year
  • ZEO N/A
  • FGEN N/A
  • P/E Ratio
  • ZEO N/A
  • FGEN N/A
  • Revenue Growth
  • ZEO N/A
  • FGEN 16.15
  • 52 Week Low
  • ZEO $1.05
  • FGEN $0.18
  • 52 Week High
  • ZEO $11.60
  • FGEN $2.80
  • Technical
  • Relative Strength Index (RSI)
  • ZEO 43.33
  • FGEN 58.51
  • Support Level
  • ZEO $2.04
  • FGEN $0.46
  • Resistance Level
  • ZEO $2.86
  • FGEN $0.51
  • Average True Range (ATR)
  • ZEO 0.24
  • FGEN 0.04
  • MACD
  • ZEO -0.07
  • FGEN 0.00
  • Stochastic Oscillator
  • ZEO 14.63
  • FGEN 72.57

About ZEO ZEO ENERGY CORP

Zeo Energy Corp is a vertically integrated provider of residential solar energy systems, other energy efficient equipment and related services currently serving customers in Florida, Texas, Arkansas, and Missouri. Its primary business activity is selling and installing residential solar energy systems that homeowners use to supplement the amount of usable electricity required to power their homes.

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.

Share on Social Networks: